国产乱人无码伦AV在线A,末成年女A∨片一区二区 ,国产高潮视频在线观看,伊人久久大香线蕉AV不卡,久久精品国产亚洲AV成人

#Vorasidenib#

1篇內(nèi)容 | 1375人圍觀

關(guān)注話(huà)題

話(huà)題活躍用戶(hù)

#插入話(huà)題

插入圖片

最新最熱

[GetTopicListResponse(id=2247501, encodeId=01b5224e50108, content=<a href='/topic/show?id=53668406668' target=_blank style='color:#2F92EE;'>#膠質(zhì)瘤#</a> <a href='/topic/show?id=41651083831e' target=_blank style='color:#2F92EE;'>#Vorasidenib#</a>, objectTitle=Vorasidenib解鎖IDH1/2突變膠質(zhì)瘤靶向治療，還有哪些問(wèn)題值得關(guān)注？, objectType=article, longId=858977, objectId=00778589e700, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250108/1736300861006_8538692.jpg, objectUrl=/article/show_article.do?id=00778589e700, replyNumber=0, likeNumber=61, createdTime=2025-01-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=00778589e700, moduleTitle=Vorasidenib解鎖IDH1/2突變膠質(zhì)瘤靶向治療，還有哪些問(wèn)題值得關(guān)注？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=00778589e700)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2220366, encodeId=620522203660a, content=<a href='/topic/show?id=41651083831e' target=_blank style='color:#2F92EE;'>#Vorasidenib#</a>是由<a href='/topic/show?id=1ba85880eda' target=_blank style='color:#2F92EE;'>#施維雅#</a>公司開(kāi)發(fā)的<a href='/topic/show?id=4942941e83' target=_blank style='color:#2F92EE;'>#IDH1#</a>和IDH2突變酶的雙重抑制劑，可通過(guò)口服給藥，能夠穿越血腦屏障，到達(dá)<a href='/topic/show?id=53668406668' target=_blank style='color:#2F92EE;'>#膠質(zhì)瘤#</a>部位，大幅提高患者的生存!! <a href='/topic/show?id=b35011e938cd' target=_blank style='color:#2F92EE;'>#沃拉西尼#</a> , objectTitle=NEJM：20多年來(lái)膠質(zhì)瘤治療的首個(gè)重大突破，大幅延長(zhǎng)患者生存期, objectType=article, longId=775467, objectId=fe17e7546715, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230606/1686014563030_5295905.jpg, objectUrl=/article/show_article.do?id=fe17e7546715, replyNumber=0, likeNumber=123, createdTime=2024-08-15, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=fe17e7546715, moduleTitle=NEJM：20多年來(lái)膠質(zhì)瘤治療的首個(gè)重大突破，大幅延長(zhǎng)患者生存期, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fe17e7546715)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2173866, encodeId=91c821e38669e, content=<a href='/topic/show?id=0b508501945' target=_blank style='color:#2F92EE;'>#腦膠質(zhì)瘤#</a> <a href='/topic/show?id=41651083831e' target=_blank style='color:#2F92EE;'>#Vorasidenib#</a> <a href='/topic/show?id=c272108384fb' target=_blank style='color:#2F92EE;'>#原發(fā)性腦腫瘤#</a>, objectTitle=讀書(shū)報(bào)告 | INDIGO研究：Vorasidenib 治療IDH1或IDH2突變的低度惡性腦膠質(zhì)瘤, objectType=article, longId=804203, objectId=984580420366, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=984580420366, replyNumber=0, likeNumber=120, createdTime=2023-12-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=984580420366, moduleTitle=讀書(shū)報(bào)告 | INDIGO研究：Vorasidenib 治療IDH1或IDH2突變的低度惡性腦膠質(zhì)瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=984580420366)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理員

腦膠質(zhì)瘤 Vorasidenib 原發(fā)性腦腫瘤

2023-12-09發(fā)表于上海

梅斯管理員 (審核中...)

前往app查看評(píng)論內(nèi)容

#膠質(zhì)瘤# #Vorasidenib#

Vorasidenib解鎖IDH1/2突變膠質(zhì)瘤靶向治療，還有哪些問(wèn)題值得關(guān)注？

2025-01-10發(fā)表于陜西省

俠膽醫(yī)心 (審核中...)

前往app查看評(píng)論內(nèi)容

#Vorasidenib#是由#施維雅#公司開(kāi)發(fā)的#IDH1#和IDH2突變酶的雙重抑制劑，可通過(guò)口服給藥，能夠穿越血腦屏障，到達(dá)#膠質(zhì)瘤#部位，大幅提高患者的生存!! #沃拉西尼#

NEJM：20多年來(lái)膠質(zhì)瘤治療的首個(gè)重大突破，大幅延長(zhǎng)患者生存期

2024-08-15發(fā)表于威斯康星

梅斯管理員 (審核中...)

前往app查看評(píng)論內(nèi)容

#腦膠質(zhì)瘤# #Vorasidenib# #原發(fā)性腦腫瘤#

讀書(shū)報(bào)告 | INDIGO研究：Vorasidenib 治療IDH1或IDH2突變的低度惡性腦膠質(zhì)瘤

2023-12-09發(fā)表于上海

科室
- - 訂閱+
  - 更多科室
工具
服務(wù)